This indicates that CARM1 is essential for oestrogen/ERα‐induced transcriptional activation, breast cancer cell growth, and tumorigenesis, making CARM1 a potential drug target for ERα‐positive and endocrine‐resistant breast cancer [82]. Here, CARM1 is linked to breast carcinoma.